Saddington Baynes

Saddington Baynes is an integrated creative production studio combining CGI, animation, visual effects and scientific storytelling. Founded in London in 1991, the business began as a digital imaging and creative retouching house before expanding into commercial production. Its current focus centres on healthcare and pharmaceutical communications, alongside experience in automotive, consumer goods, luxury and advertising.

The studio creates Mechanism of Action and Mechanism of Disease animations, molecular visualizations and campaign imagery that explain medical subjects through visual storytelling. Its healthcare work spans prescription therapeutics, medical devices, biotechnology, oncology and patient education. Productions combine scientific subject matter with character design, three-dimensional environments, motion design and live-action integration where appropriate.

Creative production and finishing

Its capabilities cover the development and delivery of both still and moving imagery. Campaign production includes print assets, animation and content for digital platforms, supported by CGI rendering, multi-pass compositing, colour grading and creative retouching. The studio also offers commercial photography and creative direction, allowing visual concepts to develop across several production disciplines.

Beyond conventional campaign assets, its interactive work includes virtual showrooms, real-time WebGL experiences and XR production environments. These capabilities complement a history of automotive visualization, product imagery and advertising work, connecting its earlier commercial practice with its present emphasis on medical and scientific content.

Business evolution

The legacy UK trading company entered administration in November 2022. Glen Taylor subsequently acquired the brand, digital assets and historical portfolio, and the business continued through new operating entities under the ALONGSIDE/ Global collective. The current studio should therefore be distinguished from the legacy legal entity that later entered liquidation.

A strategic relaunch in March 2024 sharpened its healthcare and pharmaceutical offering. Today, the studio combines generative AI tools with established CGI and artistic production techniques. Its integrated team works across New York, London and Buenos Aires, bringing creative development, technical production and finishing together for healthcare clients, brands and advertising agencies.